Our investment portfolio demonstrates focus on large unmet or underserved market opportunities with a view toward value creation and long term commitment to the healthcare sector. The breadth of our focus in each sector is illustrated by the range of therapeutic focus and diversity of technologies within our portfolio companies. Our professionals are focused on opportunities in biopharmaceuticals, medical devices and diagnostics and infrastructure technology. A selected list of our current and prior portfolio company investments is presented via the following categories:

• Biopharmaceuticals

• Information Convergence

• Medical Devices

• Biological Research Tools & Infrastructure

• Exited Investments

The companies listed do not represent a complete list of all of our team’s current and historical portfolio company investments.